GlassScriptPhysician profile
Bethany Demarco
NPI 1780201731
$2,608.40
in general payments reported to CMS, 2019-2025
16 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,214 · 2024: $987 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669 · Travel and Lodging: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,668.71 |
| Travel and Lodging | $939.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $903.92 | 2023-2025 | |
| Paragon 28, INC. | $572.44 | 2024 | Bun-Yo-Matic |
| Organogenesis INC. | $404.48 | 2023-2025 | Puraply, Affinity, Apligraf |
| Stryker Corporation | $230.55 | 2024 | Dart-Fire, Allowrap |
| Davol INC. | $148.66 | 2023 | Arista Ah Flexitip |
| Medtronic, INC. | $62.79 | 2024-2025 | Minimed 780g, Intellis Adaptivestim |
| Smith+Nephew, INC. | $53.76 | 2025 | Oasis, Grafix Pl |
| Zimmer Biomet Holdings, INC. | $42.17 | 2023 | |
| Bioventus LLC | $32.72 | 2023 | Exogen Ultrasound Bone Healing System |
| Tactile Systems Technology INC | $31.63 | 2023 | Flexitouch Plus, Entre Plus |
| Integra Lifesciences Corporation | $26.42 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bone Support INC. | $26.39 | 2025 | Ceramentbone Void Filler, Cerament G |
| Paratek Pharmaceuticals, INC. | $18.87 | 2024 | Nuzyra |
| Next Science LLC | $18.72 | 2023 | Blastx, Xperience, Surgx |
| Advanced Oxygen Therapy INC. | $17.53 | 2025 | Topical Oxygen Chamber For Extremities |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $17.35 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Demarco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.